1. Home
  2. RPID vs ABTC Comparison

RPID vs ABTC Comparison

Compare RPID & ABTC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RPID
  • ABTC
  • Stock Information
  • Founded
  • RPID 2006
  • ABTC 2024
  • Country
  • RPID United States
  • ABTC United States
  • Employees
  • RPID N/A
  • ABTC N/A
  • Industry
  • RPID Medical Specialities
  • ABTC EDP Services
  • Sector
  • RPID Health Care
  • ABTC Technology
  • Exchange
  • RPID Nasdaq
  • ABTC Nasdaq
  • Market Cap
  • RPID 106.5M
  • ABTC 122.5M
  • IPO Year
  • RPID 2021
  • ABTC N/A
  • Fundamental
  • Price
  • RPID $3.03
  • ABTC $7.89
  • Analyst Decision
  • RPID Strong Buy
  • ABTC
  • Analyst Count
  • RPID 2
  • ABTC 0
  • Target Price
  • RPID $8.00
  • ABTC N/A
  • AVG Volume (30 Days)
  • RPID 64.5K
  • ABTC 14.1M
  • Earning Date
  • RPID 10-31-2025
  • ABTC 11-08-2025
  • Dividend Yield
  • RPID N/A
  • ABTC N/A
  • EPS Growth
  • RPID N/A
  • ABTC N/A
  • EPS
  • RPID N/A
  • ABTC 2.64
  • Revenue
  • RPID $30,289,000.00
  • ABTC $69,890,000.00
  • Revenue This Year
  • RPID $16.63
  • ABTC N/A
  • Revenue Next Year
  • RPID $21.98
  • ABTC N/A
  • P/E Ratio
  • RPID N/A
  • ABTC $3.14
  • Revenue Growth
  • RPID 22.57
  • ABTC N/A
  • 52 Week Low
  • RPID $0.80
  • ABTC $6.24
  • 52 Week High
  • RPID $4.50
  • ABTC $14.52
  • Technical
  • Relative Strength Index (RSI)
  • RPID 55.88
  • ABTC N/A
  • Support Level
  • RPID $2.63
  • ABTC N/A
  • Resistance Level
  • RPID $3.11
  • ABTC N/A
  • Average True Range (ATR)
  • RPID 0.19
  • ABTC 0.00
  • MACD
  • RPID 0.09
  • ABTC 0.00
  • Stochastic Oscillator
  • RPID 89.63
  • ABTC 0.00

About RPID Rapid Micro Biosystems Inc.

Rapid Micro Biosystems Inc is an life sciences technology company providing mission critical automation solutions to facilitate the efficient manufacturing and fast, safe release of healthcare products such as biologics, vaccines, cell and gene therapies, and sterile injectables. The company's flagship Growth Direct platform automates and modernizes the antiquated, manual microbial quality control (MQC) testing workflows used in the pharmaceutical manufacturing operations across the globe. It derives revenue from development, manufacturing, marketing and selling Systems and related LIMS connection software, consumables and services.

Share on Social Networks: